Prostatic carcinoma and benign prostatic hyperplasia

Inability of MR imaging to distinguish between the two diseases

D. Ling, J. K.T. Lee, Jay Heiken, D. M. Balfe, H. S. Glazer, B. L. McClennan

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Forty patients with prostatic carcinoma or benign prostatic hyperplasia (BPH) underwent magnetic resonance (MR) imaging of the prostate. In vitro MR images of six prostate specimens were also obtained. The prostatic parenchyma was best evaluated by a T2-weighted spin-echo pulse sequence. The prostate both in patients with prostatic carcinoma and patients with BPH often had an inhomogeneous and nodular appearance on T2-weighted images. While most of the prostatic carcinomas appeared hyperintense relative to muscle and adjacent prostatic parenchyma, some of the hyperplastic nodules had a signal intensity similar to carcinoma. With current imaging techniques, MR imaging cannot differentiate prostatic carcinoma from BPH with certainty.

Original languageEnglish (US)
Pages (from-to)103-107
Number of pages5
JournalRadiology
Volume158
Issue number1
DOIs
StatePublished - Jan 1 1986
Externally publishedYes

Fingerprint

Prostatic Hyperplasia
Magnetic Resonance Imaging
Carcinoma
Prostate
Magnetic Resonance Spectroscopy
Muscles

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Prostatic carcinoma and benign prostatic hyperplasia : Inability of MR imaging to distinguish between the two diseases. / Ling, D.; Lee, J. K.T.; Heiken, Jay; Balfe, D. M.; Glazer, H. S.; McClennan, B. L.

In: Radiology, Vol. 158, No. 1, 01.01.1986, p. 103-107.

Research output: Contribution to journalArticle

Ling, D. ; Lee, J. K.T. ; Heiken, Jay ; Balfe, D. M. ; Glazer, H. S. ; McClennan, B. L. / Prostatic carcinoma and benign prostatic hyperplasia : Inability of MR imaging to distinguish between the two diseases. In: Radiology. 1986 ; Vol. 158, No. 1. pp. 103-107.
@article{ee7d4e8bbdab4be5b199c708291a136d,
title = "Prostatic carcinoma and benign prostatic hyperplasia: Inability of MR imaging to distinguish between the two diseases",
abstract = "Forty patients with prostatic carcinoma or benign prostatic hyperplasia (BPH) underwent magnetic resonance (MR) imaging of the prostate. In vitro MR images of six prostate specimens were also obtained. The prostatic parenchyma was best evaluated by a T2-weighted spin-echo pulse sequence. The prostate both in patients with prostatic carcinoma and patients with BPH often had an inhomogeneous and nodular appearance on T2-weighted images. While most of the prostatic carcinomas appeared hyperintense relative to muscle and adjacent prostatic parenchyma, some of the hyperplastic nodules had a signal intensity similar to carcinoma. With current imaging techniques, MR imaging cannot differentiate prostatic carcinoma from BPH with certainty.",
author = "D. Ling and Lee, {J. K.T.} and Jay Heiken and Balfe, {D. M.} and Glazer, {H. S.} and McClennan, {B. L.}",
year = "1986",
month = "1",
day = "1",
doi = "10.1148/radiology.158.1.2416005",
language = "English (US)",
volume = "158",
pages = "103--107",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "1",

}

TY - JOUR

T1 - Prostatic carcinoma and benign prostatic hyperplasia

T2 - Inability of MR imaging to distinguish between the two diseases

AU - Ling, D.

AU - Lee, J. K.T.

AU - Heiken, Jay

AU - Balfe, D. M.

AU - Glazer, H. S.

AU - McClennan, B. L.

PY - 1986/1/1

Y1 - 1986/1/1

N2 - Forty patients with prostatic carcinoma or benign prostatic hyperplasia (BPH) underwent magnetic resonance (MR) imaging of the prostate. In vitro MR images of six prostate specimens were also obtained. The prostatic parenchyma was best evaluated by a T2-weighted spin-echo pulse sequence. The prostate both in patients with prostatic carcinoma and patients with BPH often had an inhomogeneous and nodular appearance on T2-weighted images. While most of the prostatic carcinomas appeared hyperintense relative to muscle and adjacent prostatic parenchyma, some of the hyperplastic nodules had a signal intensity similar to carcinoma. With current imaging techniques, MR imaging cannot differentiate prostatic carcinoma from BPH with certainty.

AB - Forty patients with prostatic carcinoma or benign prostatic hyperplasia (BPH) underwent magnetic resonance (MR) imaging of the prostate. In vitro MR images of six prostate specimens were also obtained. The prostatic parenchyma was best evaluated by a T2-weighted spin-echo pulse sequence. The prostate both in patients with prostatic carcinoma and patients with BPH often had an inhomogeneous and nodular appearance on T2-weighted images. While most of the prostatic carcinomas appeared hyperintense relative to muscle and adjacent prostatic parenchyma, some of the hyperplastic nodules had a signal intensity similar to carcinoma. With current imaging techniques, MR imaging cannot differentiate prostatic carcinoma from BPH with certainty.

UR - http://www.scopus.com/inward/record.url?scp=0022647302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022647302&partnerID=8YFLogxK

U2 - 10.1148/radiology.158.1.2416005

DO - 10.1148/radiology.158.1.2416005

M3 - Article

VL - 158

SP - 103

EP - 107

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 1

ER -